You are here: Home ยป Archives for NASDAQ

Nyxoah Raises $27 Million through its At-the-Market Offering

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Raises $27 Million through its At–the–Market Offering

Investment by a new U.S.–based healthcare investor, strengthening the balance sheet and reinforcing U.S. focus

Mont–Saint–Guibert, Belgium – October 7, 2024, 11:00pm CET / 5:00pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company has sold 3.0 million shares raising $27.0 million in gross proceeds pursuant to the Company’s $50 million at–the–market (“ATM”) offering at a price per share equal to the market price on the Nasdaq Global Market at the time of sale. The shares were sold, based on interest received, to a single U.S.–based healthcare investor. Cantor Fitzgerald & Co. is acting as the sales agent for the ATM offering.

The ordinary shares described above were sold by the Company pursuant to the Company’s shelf registration statement on Form F–3 (File No. 333–268955), filed with the Securities and Exchange Commission (“SEC”) on December 22, 2022, which became effective on January 6, 2023, and which included a prospectus supplement and accompanying prospectus related to the ATM offering. Copies of the prospectus supplement and accompanying prospectus related to the ATM offering may be obtained from Cantor Fitzgerald & Co., attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022; email: prospectus@cantor.com. Electronic copies of the prospectus are also available on the SEC's website at http://www.sec.gov.

Olivier Taelman, Chief Executive Officer of Nyxoah, commented: “After relocating to the United States with my family this past summer, this investment reinforces our United States focus, builds on our compelling DREAM pivotal study data presented at the International Surgical Sleep Society (ISSS) congress and strengthens our financial position, providing additional opportunities as we are preparing for the launch of Genio® in the United States.”

About Nyxoah
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA). We are a medical technology company that develops breakthrough treatment alternatives for OSA through neuromodulation. Our first innovation is Genio®, a battery–free hypoglossal neuromodulation device that is inserted through a single incision under the chin and controlled by a wearable. Through our commitment to innovation and clinical evidence, we have shown best–in–class outcomes for reducing OSA burden.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

FORWARD–LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward–looking, which reflect the Company's or, as appropriate, the Company directors' or managements' current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and reporting data from Nyxoah’s DREAM U.S. pivotal trial; receipt of FDA approval; entrance to the U.S. market; and the anticipated closing and use of the proceeds from the offering. By their nature, forward–looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward–looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20–F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward–looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward–looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward–looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward–looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward–looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward–looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward–looking statements, which speak only as of the date of this press release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the offering, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

Contacts:

Nyxoah
Loïc Moreau, Chief Financial Officer
IR@nyxoah.com

For Media
In United States
FINN Partners – Glenn Silver
glenn.silver@finnpartners.com

In Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

In International/Germany
MC Services – Anne Hennecke
nyxoah@mc–services.eu

Attachment


GLOBENEWSWIRE (Distribution ID 1000996200)

Nyxoah Lève 27 millions de Dollars par le Biais d'une Offre sur le Marché

INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES

Nyxoah Lève 27 millions de Dollars par le Biais d'une Offre sur le Marché

Investissement d'un nouvel investisseur américain dans le secteur de la santé, renforçant le bilan et le focus sur les États–Unis

Mont–Saint–Guibert, Belgique – 7 octobre 2024, 23h00 CET / 17h00 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale développant des alternatives thérapeutiques révolutionnaires pour l'apnée obstructive du sommeil (AOS) par la neuromodulation, a annoncé aujourd'hui que la Société a vendu 3 millions d'actions, générant un produit brut de 27 millions de dollars dans le cadre de l'offre de 50 millions de dollars sur le marché (« ATM ») de la Société, à un prix par action égal au prix du marché sur le Nasdaq Global Market au moment de la vente. Les actions ont été vendues, sur la base de l'intérêt reçu, à un seul investisseur du secteur de la santé basé aux États–Unis. Cantor Fitzgerald & Co. agit en tant qu'agent de vente pour l'offre ATM.

Les actions ordinaires décrites ci–dessus ont été vendues par la Société conformément à la déclaration d'enregistrement préalable de la Société sur le Formulaire F–3 (dossier n° 333–268955), déposée auprès de la Securities and Exchange Commission (« SEC ») le 22 décembre 2022, qui est entrée en vigueur le 6 janvier 2023, et qui comprenait un supplément de prospectus et un prospectus d'accompagnement relatifs à l'offre ATM. Des copies du supplément de prospectus et du prospectus d'accompagnement relatif à l'offre ATM peuvent être obtenues auprès de Cantor Fitzgerald & Co. à l'attention de Capital Markets, 110 East 59th Street : Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022 ; courriel : prospectus@cantor.com. Des copies électroniques du prospectus sont également disponibles sur le site web de la SEC à l'adresse http://www.sec.gov.

Olivier Taelman, Chief Executive Officer de Nyxoah, a déclaré : « Après avoir déménagé aux États–Unis avec ma famille l'été dernier, cet investissement renforce notre focalisation sur les États–Unis, s'appuie sur les données convaincantes de l'étude pivot DREAM présentées au congrès de l'International Surgical Sleep Society (ISSS) et renforce notre position financière, offrant des opportunités supplémentaires alors que nous préparons le lancement de Genio® aux États–Unis. »

À propos de Nyxoah
Nyxoah réinvente le sommeil pour le milliard de personnes qui souffrent d'apnée obstructive du sommeil (AOS). Nous sommes une société de technologie médicale qui développe des alternatives de traitement révolutionnaires pour l'AOS grâce à la neuromodulation. Notre première innovation est Genio®, un dispositif de neuromodulation hypoglosse sans pile, inséré par une simple incision sous le menton et contrôlé par un dispositif portable. Grâce à notre engagement en faveur de l'innovation et des preuves cliniques, nous avons obtenu les meilleurs résultats de sa catégorie en matière de réduction du fardeau du SAOS.

Suite à l'achèvement réussi de l'étude BLAST OSA, le système Genio® a reçu son marquage CE européen en 2019. Nyxoah a réalisé deux introductions en bourse réussies : sur Euronext Bruxelles en septembre 2020 et sur le NASDAQ en juillet 2021. Suite aux résultats positifs de l'étude BETTER SLEEP, Nyxoah a reçu l'approbation du marquage CE pour l'élargissement de ses indications thérapeutiques aux patients atteints d'effondrement concentrique complet (CCC), actuellement contre–indiqués dans la thérapie des concurrents. En outre, la société a annoncé les résultats positifs de l'étude pivot DREAM IDE en vue de l'approbation de la FDA et de la commercialisation aux États–Unis.

Pour plus d'informations, veuillez consulter le rapport annuel de la société pour l'exercice 2023 et visiter le site http://www.nyxoah.com/.

Attention – Marquage CE depuis 2019. Dispositif expérimental aux États–Unis. Limité par la loi fédérale américaine à un usage expérimental aux États–Unis.

DÉCLARATIONS PROSPECTIVES

Certaines déclarations, croyances et opinions contenues dans le présent communiqué de presse sont de nature prospective et reflètent les attentes actuelles de la société ou, le cas échéant, des administrateurs ou de la direction de la société concernant le système Genio®, les études cliniques prévues et en cours sur le système Genio®, les avantages potentiels du système Genio®, les objectifs de Nyxoah concernant le développement, la voie réglementaire et l'utilisation potentielle du système Genio®, l'utilité des données cliniques pour l'obtention éventuelle de l'approbation de la FDA pour le système Genio®, et la communication des données de l'essai pivot DREAM de Nyxoah aux États–Unis, l'obtention de l'approbation de la FDA, l'entrée sur le marché américain et la clôture anticipée et l'utilisation du produit de l'offre. De par leur nature, les déclarations prospectives impliquent un certain nombre de risques, d'incertitudes, d'hypothèses et d'autres facteurs susceptibles d'entraîner une différence matérielle entre les résultats ou événements réels et ceux exprimés ou sous–entendus dans les déclarations prospectives. Ces risques, incertitudes, hypothèses et facteurs pourraient avoir une incidence négative sur les résultats et les effets financiers des plans et des événements décrits dans le présent document. En outre, ces risques et incertitudes comprennent, sans s'y limiter, les risques et incertitudes énoncés dans la section « Facteurs de risque “ du rapport annuel de la Société sur le formulaire 20–F pour l'exercice clos le 31 décembre 2023, déposé auprès de la Securities and Exchange Commission (” SEC ») le 20 mars 2024, et des rapports ultérieurs que la société dépose auprès de la SEC. Une multitude de facteurs, y compris, mais sans s'y limiter, les changements dans la demande, la concurrence et la technologie, peuvent faire en sorte que les événements, les performances ou les résultats réels diffèrent de manière significative de tout développement anticipé. Les déclarations prospectives contenues dans le présent communiqué de presse concernant des tendances ou des activités passées ne constituent pas des garanties de performances futures et ne doivent pas être considérées comme une déclaration selon laquelle ces tendances ou activités se poursuivront à l'avenir. En outre, même si les résultats ou développements réels sont conformes aux déclarations prospectives contenues dans le présent communiqué de presse, ces résultats ou développements peuvent ne pas être représentatifs des résultats ou développements des périodes futures. Aucune déclaration ou garantie n'est donnée quant à l'exactitude ou à la justesse de ces déclarations prévisionnelles. En conséquence, la Société décline expressément toute obligation ou tout engagement de publier des mises à jour ou des révisions des déclarations prospectives contenues dans le présent communiqué de presse à la suite d'un changement des attentes ou d'un changement des événements, conditions, hypothèses ou circonstances sur lesquels ces déclarations prospectives sont basées, sauf si la loi ou la réglementation l'exige expressément. Ni la Société, ni ses conseillers ou représentants, ni aucune de ses filiales, ni les dirigeants ou employés de ces personnes ne garantissent que les hypothèses sous–jacentes à ces déclarations prospectives sont exemptes d'erreurs et n'acceptent aucune responsabilité quant à l'exactitude future des déclarations prospectives contenues dans ce communiqué de presse ou quant à la survenance effective des développements prévus. Vous ne devriez pas accorder une confiance excessive aux déclarations prospectives, qui ne sont valables qu'à la date du présent communiqué de presse.

Le présent communiqué de presse ne constitue pas une offre de vente ou une sollicitation d'une offre d'achat des titres faisant l'objet de l'offre, et il n'y aura pas de vente de ces titres dans une juridiction où une offre, une sollicitation ou une vente serait illégale avant l'enregistrement ou la qualification en vertu des lois sur les valeurs mobilières de cette juridiction.

Contacts :

Nyxoah
Loïc Moreau, Chief Financial Officer
IR@nyxoah.com

For Media
In United States
FINN Partners – Glenn Silver
glenn.silver@finnpartners.com

In Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

In International/Germany
MC Services – Anne Hennecke
nyxoah@mc–services.eu

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1000996200)

Zoom Phone Now Available in India

SAN JOSE, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced the launch of its industry–leading Zoom Phone in India, commencing with the availability of Zoom Phone service with native India phone numbers in the Maharashtra Telecom Circle (Pune). Zoom Phone brings multinational corporations (MNCs) with a domestic presence and homegrown companies unrivaled simplicity and modern functionality to their distributed hybrid workforce, as well as global native coverage in 50 countries and territories.

The native phone number support will be available starting with the Maharashtra Telecom Circle (Pune), followed by Karnataka (Bangalore), Tamil Nadu (Chennai), Andhra Pradesh (Hyderabad), Mumbai and Delhi telecom circles, covering all the major technology centers in India.

Zoom India received the Unified License with Access — All/PAN India and Long Distance licenses from the Department of Telecommunications (DoT), Government of India, in April 2023. Thereafter, Zoom India focused on establishing its dedicated domestic infrastructure for Zoom Phone in India and complying with regulatory requirements. This effort enables Zoom to lead the industry with the launch of the first–of–its–kind licensed cloud private branch exchange (PBX) service bundled with local phone numbers for India.

“Zoom’s cloud PBX service meets the requirements of India’s Unified Telecom license which requires building the dedicated local interconnection infrastructure in accordance with the regulatory requirements. This demonstrates Zoom’s commitment to bringing a trusted service that our customers want,” said Velchamy Sankarlingam, president of product and engineering, Zoom. “Globally, Zoom Phone saw continued expansion in the market, amassing five Zoom Phone customers with 100k+ seats in Q1 FY251, demonstrating our customers’ trust in Zoom for critical employee and customer experience processes. Our latest offering reaffirms Zoom’s leadership in delivering seamless cloud services on a global scale, enhanced by local investments to help ensure compliance and service excellence in every market, including India.”

With an intuitive and familiar interface, Zoom Phone offers reliable, secure, and flexible voice communication features that seamlessly integrate with Zoom Workplace, the company’s open collaboration platform with Zoom AI Companion. Zoom Phone provides local telephony services and is available as an add–on to Zoom's existing paid customers. With support for inbound and outbound calling through the public switched telephone network (PSTN), enterprise customers can seamlessly replace their existing PBX solution and consolidate their business communication requirements into one platform.

“We are excited to bring Zoom Phone to India, first rolling it out in the Maharashtra Telecom Circle (Pune), empowering multinational enterprises and homegrown companies of all sizes to support dynamic workstyles, improve employee engagement, and elevate the customer experience,” said Sameer Raje, general manager and head of India & SAARC region, Zoom. “The launch of Zoom Phone marks a significant milestone in Zoom’s commitment to the Indian market. This achievement represents our dedication to delivering a reliable collaboration platform that powers limitless human connection and solves real business problems for our customers.”

In addition to its comprehensive features, Zoom Phone is now boosted with AI Companion capabilities to enhance call productivity. Users can request post–call summaries and next steps, allowing them to focus on conversations instead of taking notes. Voicemail prioritization elevates urgent messages, moving them to the top of the queue, while voicemail task extraction delivers tasks from voicemails, helping users understand the next steps without listening to every message. Zoom Phone integrates with leading business applications, contact center partners, and hardware providers, offering an all–in–one collaboration platform for MNCs with a domestic presence and businesses of all sizes.

“The availability of Zoom Phone is timely, reflecting the trend of strong demand for Unified Communications as a Service solutions integrated with telephony in India. By offering a single platform with enterprise–class features, Zoom Phone addresses the growing modern collaboration needs of local companies and global businesses with presence in India as they look to unify their employee and customer communication channels with a solid foundation in voice,” said Krishna Baidya, senior industry director, Frost & Sullivan. “In addition to streamlining communications with one platform, Zoom Phone stands out with its scalability, security, and user–friendly interface.”

To learn more about Zoom Phone, please visit the Zoom Phone page.

About Zoom
Zoom’s mission is to provide one platform that delivers limitless human connection. Reimagine teamwork with Zoom Workplace — Zoom’s open collaboration platform with AI Companion empowers teams to be more productive. Together with Zoom Workplace, Zoom’s Business Services for sales, marketing, and customer care teams, including Zoom Contact Center, strengthen customer relationships throughout the customer lifecycle. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more information at zoom.com.

Zoom Press Contact
Hayley Yap
APAC Communications Lead
press@zoom.us

1 https://investors.zoom.us/static–files/213084f3–4584–4e9f–8e74–fe5d9741cec2


GLOBENEWSWIRE (Distribution ID 9250566)

LeddarTech Apresenta a LeddarVision na AutoSens Europe: Inovação Orientada por IA Aprimorada com Processadores de TI e Colaboração Arm

QUEBEC CITY, Canadá, Oct. 03, 2024 (GLOBE NEWSWIRE) — A LeddarTech®Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), uma empresa de software automotivo que fornece a tecnologia patenteada de software de fusão e percepção de sensores de baixo nível com base em IA LeddarVision™, para ADAS, AD e aplicações de estacionamento, tem o orgulho de destacar as contribuições essenciais da Texas Instruments e da Arm no aprimoramento dos seus revolucionários produtos LeddarVision.

Os clientes são convidados a conhecer o futuro da inovação automotiva com o demonstrador LeddarNavigator da LeddarTech na AutoSens Europe (8 a 10 de outubro de 2024). Esta vitrine de última geração exibe o software avançado de fusão e percepção de sensores com base em IA da empresa, o LeddarVision, destacando o poder transformador da tecnologia de processadores líder do setor. Habilitada pelo processador TDA4VE–Q1 da Texas Instruments e integração perfeita dos processadores automotivos da Arm, esta tecnologia de software define um novo padrão em desempenho e capacidade.

Destaque das Contribuições da Arm e TI no Conjunto de Produtos LeddarVision:

  • A Arm impulsiona a inovação do ADAS com plataformas de computação avançadas projetadas para atender às necessidades de segurança e desempenho de casos de uso automotivo. Seu papel crucial no aprimoramento da eficiência da LeddarVision é evidente. Ao otimizar algoritmos essenciais de definição de desempenho dentro da percepção ADAS e pilha de fusão para CPUs Arm, a Arm e a LeddarTech minimizaram com sucesso os gargalos computacionais e aprimoraram a eficiência geral do sistema com o uso do CPU ARM Cortex–A720AE.

Veja de perto esta colaboração inovadora. Este Estudo de Caso apresenta um relato detalhado da jornada das duas empresas na expansão dos limites da inovação e na vanguarda do futuro da segurança automotiva.

  • O processador da família TDA4 altamente integrado e econômico da Texas Instruments (TI) é usado na solução Front–Entry da LeddarVision (LVF–E), a primeira solução abrangente de percepção baseada em fusão de baixo nível do mercado implantada em um único processador TDA4VE–Q1. Com uma implementação eficiente na plataforma TDA4VE–Q1, ele alcança um dos custos de sistema mais baixos de ADAS de nível básico L2/L2+ sem sacrificar o desempenho do sistema. O TDA4VE–Q1, realizando processamento de fusão de sensores de baixo nível, fornece computação de alto desempenho para algoritmos de visão tradicional e de aprendizagem profunda, e aceleração de pré–processamento de visão para alcançar um alto nível de integração do sistema com baixa energia e custos do sistema. Os membros compatíveis com PIN e software da família de produtos TDA4 permitem escalabilidade em sistemas de maior desempenho ou menor custo para aplicações avançadas de fusão de sensores ADAS simples e multimodais.

“Com o aproveitamento dos pontos fortes da Texas Instruments e da Arm, aprimoramos a funcionalidade da LeddarVision e contribuímos para o futuro da segurança e autonomia automotiva. Juntos, estamos reformulando os padrões do setor”, disse Heinz Oyrer, Diretor de Parcerias Estratégicas da LeddarTech.

Marque uma consulta com a LeddarTech na AutoSens Europe para uma demonstração ao vivo no LeddarNavigator e confira os benefícios dos produtos LeddarVision de fusão de baixo nível baseados em IA, incluindo o LVS–2 + e o LVF–E. Essas soluções são projetadas para atender aos rigorosos padrões de segurança NCAP 2025/GSR 2022 de 5 estrelas e são validadas por meio de pesquisa e desenvolvimento rigorosos em nossas instalações em Tel Aviv, Montreal e Quebec City. Os principais indicadores de desempenho estão disponíveis para avaliação dos clientes mediante solicitação.

Acompanhe a viagem pela Europa no nosso site “LeddarNavigator Diaries“.

Sobre a LeddarTech

Uma empresa global de software fundada em 2007 e sediada na cidade de Quebec, com centros adicionais de P&D em Montreal e Tel Aviv, Israel, a LeddarTech desenvolve e fornece soluções abrangentes de software de percepção e fusão de baixo nível com base em IA que permitem a implantação de aplicações ADAS, de condução autônoma (AD) e de estacionamento. O software de nível automotivo da LeddarTech aplica algoritmos avançados de IA e visão computacional para gerar modelos 3D precisos do ambiente para tomadas de decisões melhores e navegação mais segura. Esta tecnologia de alto desempenho, escalonável e econômica é disponível para OEMs e fornecedores de Nível 1–2 para a implementação eficiente de soluções ADAS para veículos automotivos e off–road.

A LeddarTech é responsável por várias inovações de sensor remoto, com mais de 160 patentes solicitadas (87 concedidas) que aprimoram os recursos de ADAS, AD e de estacionamento. A percepção de veículos é fundamental para tornar a mobilidade global mais segura, eficiente, sustentável e acessível: e é por isso que a LeddarTech deseja se tornar a solução de software de fusão e percepção de sensores mais amplamente adotada.

A LeddarTech pode ocasionalmente, no âmbito de colaborações, parcerias e projetos, coletar com veículos de teste informações pessoais, ou seja, informações que identifiquem direta ou indiretamente membros do público. As informações pessoais coletadas podem ser processadas, usadas, armazenadas e comunicadas pela LeddarTech no âmbito do desenvolvimento e treinamento dos nossos softwares e produtos. Para obter mais informações sobre as atividades de processamento, que incluem a coleta, uso, armazenamento e comunicação das informações pessoais, bem como os direitos de proteção das informações pessoais associados e como exercê–los, consulte a Política de Privacidade da LeddarTech.

Para mais informação sobre a LeddarTech, visite www.LeddarTech.com, LinkedIn, Twitter (X), Facebook e YouTube.

Declarações de Previsão

Certas declarações contidas neste comunicado de imprensa podem ser consideradas declarações de previsão na acepção da Lei de Reforma de Litígios de Títulos Privados dos EUA de 1995, Seção 27A da Lei de Títulos e Valores Mobiliários e Seção 21E da Lei de Câmbio (cujas declarações de previsão também devem incluir declarações de previsão e informações de previsão na acepção das leis de valores mobiliários canadenses aplicáveis), incluindo, mas não se limitando a, declarações relacionadas à estratégia antecipada, operações futuras, perspectivas, objetivos e projeções financeiras e outras métricas financeiras da LeddarTech. As declarações de previsão geralmente incluem declarações de natureza preditiva e dependem ou se referem a eventos ou condições futuras, e incluem palavras como “pode”, “irá”, “deveria”, “esperaria”, “antecipa”, “planeja”, “provável”, “acredita”, “estima”, “projeta”, “pretende e outras expressões semelhantes, entre outras. Declarações que não sejam de fatos históricos são declarações de previsão. Declarações de previsão tomam por base convicções e suposições atuais sujeitas a riscos e incertezas e não são garantias de desempenho futuro. Os resultados reais podem ser substancialmente diferentes dos resultados contidos em qualquer declaração de previsão devido a vários fatores, incluindo, sem limitação: (i) a possibilidade de que os benefícios antecipados da recente união das empresas da LeddarTech não sejam realizados; (ii) o risco de que litígios de acionistas em conexão com a união das empresas ou outros acordos ou investigações possam resultar em custos significativos de defesa, indenização e responsabilidade; (iii) mudanças nas condições econômicas gerais e/ou específicas do setor; (iv) possíveis interrupções da união das empresas que possam prejudicar os negócios da LeddarTech; (v) a capacidade da LeddarTech de reter, atrair e contratar pessoal essencial; (vi) possíveis reações adversas ou mudanças no relacionamento com os clientes, funcionários, fornecedores ou outras partes; (vii) potencial incerteza nos negócios, incluindo mudanças nas relações comerciais existentes após a união das empresas que possam afetar o desempenho financeiro da LeddarTech; (viii) desenvolvimentos legislativos, regulatórios e econômicos; (ix) imprevisibilidade e gravidade de eventos catastróficos, incluindo, mas não se limitando a, atos de terrorismo, surto ou escalada de guerra ou hostilidades e qualquer epidemia, pandemia ou surto de doença (incluindo COVID–19), bem como a resposta da administração a qualquer um dos fatores acima mencionados; (x) acesso a capital e financiamento, e capacidade de manter o cumprimento dos acordos de dívida; (xi) a capacidade da LeddarTech de executar seu modelo de negócios, obter ganhos com projetos e gerar receita significativa; e (xii) outros fatores de risco, conforme detalhado ocasionalmente nos relatórios da LeddarTech arquivados na Comissão de Valores Mobiliários dos EUA (a “SEC”), incluindo os fatores de risco contidos no Relatório Anual da LeddarTech no Formulário 20–F para o exercício fiscal encerrado em 30 de setembro de 2023. A lista anterior de fatores importantes não é exaustiva. Exceto conforme exigido pela lei aplicável, a LeddarTech não assume qualquer obrigação de revisar ou atualizar qualquer declaração de previsão, ou de fazer quaisquer outras declarações de previsão, seja como resultado de novas informações, eventos futuros ou de outra forma.

Contato:
Daniel Aitken, Vice–Presidente, Marketing Global, Comunicações e Relacionamento com o Investidor, LeddarTech Holdings Inc. Tel.: + 1–418–653–9000 ramal 232 daniel.aitken@LeddarTech.com

Os logotipos Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision e afins são marcas comerciais ou marcas comerciais registradas da LeddarTech Holdings Inc. e suas subsidiárias. Todas as outras marcas e nomes de produtos são ou podem ser marcas comerciais ou marcas comerciais registradas usadas para identificar produtos ou serviços de seus respectivos proprietários.

LeddarTech Holdings Inc. é uma empresa pública listada na Nasdaq sob o símbolo “LDTC”.

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/7207016b–6eb5–4c0e–8821–f52cb6a9c84b


GLOBENEWSWIRE (Distribution ID 9250262)

LeddarTech présente LeddarVision à AutoSens Europe : une innovation pilotée par l’IA, optimisée par les processeurs Texas Instruments et une collaboration avec Arm

QUÉBEC, Canada, 03 oct. 2024 (GLOBE NEWSWIRE) — LeddarTech® Holdings Inc. (« LeddarTech ») (NASDAQ : LDTC), une société de logiciels automobiles qui fournit des technologies logicielles de fusion bas niveau de capteurs et de perception reposant sur l’IA, innovatrices et brevetées pour systèmes avancés d’aide à la conduite (systèmes ADAS), de conduite autonome (systèmes AD) et de stationnement, est fière de souligner les contributions essentielles de Texas Instruments et de Arm dans le perfectionnement de sa famille de solutions de rupture LeddarVision™.

Les clients sont invités à embarquer dans l’innovation automobile avec le démonstrateur LeddarNavigator de LeddarTech lors de l’événement AutoSens Europe (8–10 octobre 2024). Cette vitrine technologique inédite présente le logiciel avancé de fusion de capteurs et de perception basé sur l’IA de l’entreprise, LeddarVision, et met en lumière le potentiel transformateur de la technologie des processeurs de nouvelle génération. Propulsée par le processeur TDA4VE–Q1 de Texas Instruments et intégrant de manière transparente les processeurs automobiles de Arm, cette technologie logicielle établit une nouvelle norme en termes de performances et de capacités.

Contributions de Arm et de TI à la suite de produits LeddarVision :

  • Arm stimule l’innovation dans l’ADAS grâce à des plateformes de calcul avancées conçues pour répondre aux besoins de sécurité et de performance des cas d’utilisation automobile. Leur contribution à l’amélioration de l’efficacité de LeddarVision est manifeste. En optimisant les algorithmes critiques qui définissent la performance de la solution de perception et de fusion des processeurs Arm en matière d’ADAS, Arm et LeddarTech ont réussi à réduire les goulets d’étranglement computationnels et à améliorer l’efficacité globale du système grâce au processeur Cortex–A720AE de Arm.

Découvrez de plus près cette collaboration d’exception. Cette étude de cas (en anglais) décrit en détail le parcours des deux organisations, qui repoussent les limites de l’innovation et ouvrent la voie à l’avenir de la sécurité automobile.

  • Le processeur hautement intégré et économique de la famille TDA4 de Texas Instruments (TI) est utilisé pour le LeddarVision frontal d’entrée de gamme (LVF–E), qui constitue la première solution complète de perception basée sur la fusion bas niveau à être déployée sur un processeur TDA4VE–Q1 unique. Le recours judicieux au TDA4VE–Q1 permet d’obtenir des coûts parmi les plus bas pour un système ADAS de niveau 2/2+ d’entrée de gamme sans sacrifier la performance du système. Le TDA4VE–Q1, qui assure la fusion bas niveau des données de capteurs, offre une puissance de calcul élevée tant pour les algorithmes de vision traditionnels que d’apprentissage profond ainsi qu’une accélération du prétraitement de la vision afin d’atteindre un niveau élevé d’intégration système avec une faible consommation d’énergie et à moindre coût. La compatibilité des produits de la famille TDA4 permet une évolutivité vers des systèmes plus performants ou moins coûteux pour les applications avancées de fusion de capteurs ADAS monomodales et multimodales.

« En tirant parti des forces de Texas Instruments et de Arm, nous améliorons les fonctionnalités de LeddarVision et collaborons à l’avenir de la sécurité et de l’autonomie automobiles. Ensemble, nous redéfinissons les normes de l’industrie », a déclaré Heinz Oyrer, directeur des partenariats stratégiques chez LeddarTech.

Prenez rendez–vous avec LeddarTech lors d’AutoSens Europe pour une démonstration en direct de la LeddarNavigator et explorez les avantages de la fusion bas niveau basée sur l’IA avec LeddarVision, notamment le LVS–2+ et le LVF–E. Ces solutions sont conçues pour répondre aux exigences sévères des normes de sécurité 5 étoiles NCAP 2025/GSR 2022 et sont validées par une démarche de recherche et développement rigoureuse dans nos installations de Tel Aviv, Montréal et Québec. Les indicateurs de performance clés sont disponibles pour consultation par les clients sur demande.

Suivez la tournée européenne sur notre site « Journal LeddarNavigator Diaries ».

À propos de LeddarTech

Entreprise mondiale de logiciels fondée en 2007, basée à Québec et disposant de centres de R&D supplémentaires à Montréal et Tel Aviv (Israël), LeddarTech développe et propose des solutions logicielles complètes de fusion bas niveau de capteurs et de perception reposant sur l’intelligence artificielle qui permettent le déploiement d’applications ADAS, de conduite autonome (AD) et de stationnement. Les logiciels de classe automobile de LeddarTech appliquent des algorithmes d’intelligence artificielle et de vision numérique avancés afin de générer des modèles 3D précis de l’environnement, pour une meilleure prise de décision et une navigation plus sûre. Cette technologie performante, évolutive et économique permet la mise en œuvre efficace de solutions ADAS pour véhicules automobiles et hors route par les équipementiers et les fournisseurs de rang 1 et 2.

Ayant déposé plus de 160 demandes de brevets (dont 87 accordées) qui améliorent les capacités des systèmes d’aide à la conduite, de conduite autonome et de stationnement, l’entreprise a contribué à plusieurs innovations liées à des applications de télédétection. Une plus grande conscience situationnelle est essentielle pour rendre la mobilité plus sûre, plus efficace, plus durable et plus abordable : c’est ce qui motive LeddarTech à vouloir devenir la solution logicielle de fusion de capteurs et de perception la plus largement adoptée.

LeddarTech peut, de temps à autre, dans le cadre de collaborations, de partenariats ou de projets, recueillir avec des véhicules d’essai des renseignements personnels, c.–à–d., des renseignements qui identifient directement ou indirectement des membres du public. Les renseignements personnels peuvent être traités, utilisés, stockés et communiqués par LeddarTech dans le contexte du développement et de l’amélioration de nos logiciels et de nos produits. Pour plus d’information sur les activités de traitement, y compris la collecte, l’utilisation, le stockage et la communication des renseignements personnels, ainsi que sur les droits en matière de protection des renseignements personnels associés et la manière de les exercer, consultez la Politique de confidentialité de LeddarTech.

Renseignements complémentaires disponibles sur www.LeddarTech.com et sur LinkedIn, Twitter (X), Facebook et YouTube.

Énoncés prospectifs

Certains énoncés contenus dans le présent communiqué de presse peuvent être considérés comme des énoncés prospectifs au sens du Private Securities Litigation Reform Act de 1995 des États–Unis, de la section 27A du Securities Act de 1933, tel que modifié, et de la section 21E du Securities Exchange Act de 1934, tel que modifié (lesquels énoncés prospectifs comprennent également les énoncés prospectifs et les renseignements prospectifs au sens des lois canadiennes sur les valeurs mobilières applicables), y compris, mais sans s’y limiter, les énoncés relatifs à la stratégie, aux activités futures, aux perspectives, aux objectifs et aux projections financières et autres mesures financières anticipés de LeddarTech. Les énoncés prospectifs comprennent généralement des énoncés de nature prévisionnelle qui dépendent d’événements ou de conditions à venir ou qui s’y réfèrent, et comprennent des termes tels que « pouvoir », « anticiper », « prévoir », « avoir l’intention de », « estimer », « planifier », « croire », « s’attendre à », « projeter de » et autres expressions similaires et verbes au futur et au conditionnel notamment. Les énoncés qui ne sont pas des faits historiques sont des énoncés prospectifs. Les énoncés prospectifs reposent sur des convictions et des hypothèses actuelles qui sont soumises à des risques et à des incertitudes et ne constituent pas des garanties de performance future. Les résultats réels peuvent différer sensiblement de ceux contenus dans un énoncé prospectif en raison de divers facteurs, y compris, mais sans s’y limiter : (i) la possibilité que les avantages anticipés du récent regroupement d’entreprises de LeddarTech ne se réalisent pas; (ii) le risque que des litiges entre actionnaires liés au regroupement d’entreprises ou autres règlements ou enquêtes entraînent des coûts importants de défense, d’indemnisation et de responsabilité; (iii) l’évolution de la conjoncture économique générale et/ou des conditions propres à l’industrie; (iv) les éventuelles perturbations dues au regroupement d’entreprises susceptibles de nuire aux activités de LeddarTech; (v) la capacité de LeddarTech à retenir, à attirer et à embaucher du personnel clé; (vi) les réactions ou changements négatifs potentiels dans les relations avec les clients, employés, fournisseurs ou autres parties; (vii) l’incertitude commerciale potentielle, y compris les changements dans les relations commerciales existantes suivant le regroupement d’entreprises, susceptible d’affecter la performance financière de LeddarTech; (viii) les développements législatifs, réglementaires et économiques; (ix) l’imprévisibilité et la gravité d’événements catastrophiques, y compris, mais sans s’y limiter, les actes de terrorisme, le déclenchement ou l’escalade d’une guerre ou d’hostilités et toute épidémie, pandémie ou apparition de maladie (y compris la COVID–19), ainsi que la réponse de la direction à l’un des facteurs susmentionnés; (x) l’accès au capital et au financement et la capacité de LeddarTech à maintenir le respect des clauses restrictives de ses emprunts; (xi) la capacité de LeddarTech à exécuter son modèle d’affaires, à remporter des contrats de conception et à générer des revenus significatifs; et (xii) les autres facteurs de risque détaillés de temps à autre dans les rapports de LeddarTech déposés auprès de la U.S. Securities and Exchange Commission (la « SEC »), y compris les facteurs de risque figurant dans le rapport annuel de LeddarTech sur le formulaire 20–F pour l’exercice financier terminé le 30 septembre 2023. La liste des facteurs importants ci–dessus n’est pas exhaustive. Sauf si la loi applicable l’exige, LeddarTech ne s’engage pas à réviser ou à mettre à jour les énoncés prospectifs, ni à mentionner d’autres énoncés prospectifs, que ce soit à la suite de nouvelles informations, d’événements futurs ou autres.

Contact :
Daniel Aitken, vice–président, Marketing, communications et relations avec les investisseurs mondiaux, LeddarTech Holdings Inc.
Tél. : + 1–418–653–9000 poste 232 daniel.aitken@LeddarTech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision et les logos associés sont des marques de commerce ou des marques déposées de LeddarTech Holdings Inc. et de ses filiales. Tous les autres noms de marques, noms de produits et marques sont ou peuvent être des marques de commerce ou des marques déposées utilisées pour désigner les produits ou les services de leurs propriétaires respectifs.

LeddarTech Holdings Inc. est une société publique cotée au NASDAQ sous le symbole « LDTC ».

Une photo accompagnant ce communiqué est disponible au 
https://www.globenewswire.com/NewsRoom/AttachmentNg/7207016b–6eb5–4c0e–8821–f52cb6a9c84b


GLOBENEWSWIRE (Distribution ID 9248809)

LeddarTech Showcases LeddarVision at AutoSens Europe: AI-Driven Innovation Enhanced With TI Processors and Arm Collaboration

QUEBEC CITY, Canada, Oct. 03, 2024 (GLOBE NEWSWIRE) — LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI–based low–level sensor fusion and perception software technology, LeddarVision™, for ADAS, AD and parking applications, proudly highlights the critical contributions of Texas Instruments and Arm in enhancing its groundbreaking LeddarVision products.

Customers are invited to experience the future of automotive innovation with LeddarTech’s LeddarNavigator demonstrator at AutoSens Europe (October 8–10, 2024). This state–of–the–art showcase demonstrates the company’s advanced AI–based sensor fusion and perception software, LeddarVision, and underscores the transformative power of industry–leading processor technology. Enabled by Texas Instruments’ TDA4VE–Q1 processor and seamlessly integrating Arm’s automotive processors, this software technology sets a new standard in performance and capability.

Featuring the Contributions of Arm and TI to the LeddarVision Suite of Products:

  • Arm drives ADAS innovation with advanced compute platforms designed to address the safety and performance needs of automotive use cases. Their crucial role in enhancing LeddarVision’s efficiency is evident. By optimizing critical performance–defining algorithms within the ADAS perception and fusion stack for Arm CPUs, Arm and LeddarTech have successfully minimized computational bottlenecks and enhanced overall system efficiency using the Arm Cortex–A720AE CPU.

Take a closer look at this groundbreaking collaboration. This Case Study provides a detailed account of the two organizations’ journey as they push the boundaries of innovation and pioneer the future of automotive safety.

  • Texas Instruments’ (TI) highly integrated and cost–efficient TDA4 family processor is used for the LeddarVision Front–Entry solution (LVF–E), which marked the first–to–market comprehensive low–level–fusion based perception solution deployed on a single TDA4VE–Q1 processor. The efficient implementation on the TDA4VE–Q1 processor achieves one of the lowest system costs for L2/L2+ entry–level ADAS without sacrificing system performance. The TDA4VE–Q1, performing low–level sensor fusion processing, provides high–performance computing for both traditional vision and deep learning algorithms and vision pre–processing acceleration to achieve a high level of system integration at low system power and costs. Pin and software–compatible members of the TDA4 product family enable scalability to higher–performance or lower–cost systems for advanced single and multi–modal ADAS sensor fusion applications.

“By leveraging the strengths of Texas Instruments and Arm, we are enhancing the functionality of LeddarVision and contributing to the future of automotive safety and autonomy. Together, we are reshaping industry standards,” stated Heinz Oyrer, Director of Strategic Partnerships at LeddarTech.

Book an appointment with LeddarTech at AutoSens Europe for a live demonstration in the LeddarNavigator and witness the benefits of AI–based low–level fusion LeddarVision products, including the LVS–2+ and LVF–E. These solutions are engineered to meet the stringent 5–star NCAP 2025/GSR 2022 safety standards and are validated through rigorous research and development at our Tel Aviv, Montreal and Quebec City facilities. Key performance indicators are available to customers for review upon request.

Follow the European road trip journey on our “LeddarNavigator Diaries” site.

About LeddarTech

A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal and Tel Aviv, Israel, LeddarTech develops and provides comprehensive AI–based low–level sensor fusion and perception software solutions that enable the deployment of ADAS, autonomous driving (AD) and parking applications. LeddarTech’s automotive–grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment to achieve better decision making and safer navigation. This high–performance, scalable, cost–effective technology is available to OEMs and Tier 1–2 suppliers to efficiently implement automotive and off–road vehicle ADAS solutions.

LeddarTech is responsible for several remote–sensing innovations, with over 160 patent applications (87 granted) that enhance ADAS, AD and parking capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

LeddarTech might, in the scope of collaborations, partnerships and projects, from time to time, collect with test vehicles personal information, i.e., information that directly or indirectly identifies members of the public. Collected personal information may be processed, used, stored and communicated by LeddarTech within the scope of developing and training our software and products. For further information about the processing activities, which include the collection, use, storage and communication of the personal information, as well as the associated personal information protection rights and how to exercise them, please consult LeddarTech’s Privacy Policy.

Additional information about LeddarTech is accessible at www.LeddarTech.com and on LinkedIn, Twitter (X), Facebook and YouTube.

Forward–Looking Statements

Certain statements contained in this Press Release may be considered forward–looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which forward–looking statements also include forward–looking statements and forward–looking information within the meaning of applicable Canadian securities laws), including, but not limited to, statements relating to LeddarTech’s anticipated strategy, future operations, prospects, objectives and financial projections and other financial metrics. Forward–looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend” and other similar expressions among others. Statements that are not historical facts are forward–looking statements. Forward–looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward–looking statement as a result of various factors, including, without limitation: (i) the possibility that anticipated benefits of LeddarTech’s recent business combination will not be realized; (ii) the risk that shareholder litigation in connection with the business combination or other settlements or investigations may result in significant costs of defense, indemnification and liability; (iii) changes in general economic and/or industry–specific conditions; (iv) possible disruptions from the business combination that could harm LeddarTech’s business; (v) the ability of LeddarTech to retain, attract and hire key personnel; (vi) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties; (vii) potential business uncertainty, including changes to existing business relationships following the business combination that could affect LeddarTech’s financial performance; (viii) legislative, regulatory and economic developments; (ix) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak or escalation of war or hostilities and any epidemic, pandemic or disease outbreak (including COVID–19), as well as management’s response to any of the aforementioned factors; (x) access to capital and financing and LeddarTech’s ability to maintain compliance with debt covenants; (xi) LeddarTech’s ability to execute its business model, achieve design wins and generate meaningful revenue; and (xii) other risk factors as detailed from time to time in LeddarTech’s reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including the risk factors contained in LeddarTech’s Annual Report on Form 20–F for the fiscal year ended September 30, 2023. The foregoing list of important factors is not exhaustive. Except as required by applicable law, LeddarTech does not undertake any obligation to revise or update any forward–looking statement, or to make any other forward–looking statements, whether as a result of new information, future events or otherwise.

Contact:
Daniel Aitken, Vice–President, Global Marketing, Communications and Investor Relations, LeddarTech Holdings Inc. Tel.: + 1–418–653–9000 ext. 232 daniel.aitken@LeddarTech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Holdings Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

LeddarTech Holdings Inc. is a public company listed on the Nasdaq under the ticker symbol “LDTC.”

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7207016b–6eb5–4c0e–8821–f52cb6a9c84b


GLOBENEWSWIRE (Distribution ID 9248809)

LeddarTech stellt LeddarVision auf der AutoSens Europe vor: KI-gesteuerte Innovation verbessert durch TI-Prozessoren und Kooperation mit Arm

QUEBEC CITY, Kanada, Oct. 03, 2024 (GLOBE NEWSWIRE) — LeddarTech®Holdings Inc. („LeddarTech“) (Nasdaq: LDTC), ein Softwareunternehmen für die Automobilindustrie, das patentierte, bahnbrechende KI–basierte Low–Level–Sensorfusion und Wahrnehmungssoftwaretechnologie, LeddarVision™, für ADAS–, AD– und Parkanwendungen anbietet, gibt mit Freude entscheidende Beiträge von Texas Instruments und Arm zur Verbesserung seiner bahnbrechenden LeddarVision–Produkte bekannt.

Kunden sind eingeladen, die Zukunft der Automobilinnovation mit der LeddarNavigator–Demonstrationeinheit von LeddarTech auf der AutoSens Europe (8.–10. Oktober 2024) zu erleben. Dieser hochmoderne Showcase demonstriert die fortschrittliche KI–basierte Sensorfusions– und Wahrnehmungssoftware LeddarVision des Unternehmens und unterstreicht die transformative Kraft der branchenführenden Prozessortechnologie. Mit dem TDA4VE–Q1–Prozessor von Texas Instruments und der nahtlosen Integration der Automotive–Prozessoren von Arm setzt diese Softwaretechnologie neue Maßstäbe in Bezug auf Leistung und Funktionsfähigkeit.

Vorstellung der Beiträge von Arm und TI zur LeddarVision–Produktreihe:

  • Arm treibt ADAS–Innovationen mit fortschrittlichen Rechenplattformen voran, die auf die Sicherheits– und Leistungsanforderungen von Automobilanwendungen zugeschnitten sind. Die entscheidende Rolle des Unternehmens bei der Steigerung der Effizienz von LeddarVision ist offensichtlich. Durch die Optimierung kritischer, leistungsbestimmender Algorithmen innerhalb des ADAS–Wahrnehmungs– und Fusions–Stacks für Arm–CPUs haben Arm und LeddarTech erfolgreich Berechnungsengpässe minimiert und die Gesamtsystemeffizienz mit der Arm Cortex–A720AE CPU verbessert.

Werfen Sie einen genaueren Blick auf diese bahnbrechende Zusammenarbeit. Diese Fallstudie gibt einen detaillierten Überblick über die Zusammenarbeit der beiden Unternehmen, die die Grenzen der Innovation erweitern und die Zukunft der Automobilsicherheit vorantreiben.

  • Der hochintegrierte und kosteneffiziente Prozessor der TDA4–Familie von Texas Instruments (TI) wird für die LeddarVision Front–Entry–Lösung (LVF–E) verwendet, die als erste umfassende Low–Level–Fusion–basierte Wahrnehmungslösung auf einem einzigen TDA4VE–Q1)–Prozessor auf den Markt kommt. Durch die effiziente Implementierung auf dem TDA4VE–Q1–Prozessor wird eine der niedrigsten Systemkosten für L2/L2+–ADAS der Einstiegsklasse erreicht, ohne dass die Systemleistung darunter leidet. Der TDA4VE–Q1, der eine Low–Level–Sensorfusionsverarbeitung durchführt, bietet Hochleistungsrechner für herkömmliche Bildverarbeitungs– und Deep–Learning–Algorithmen sowie eine Beschleunigung der Bildverarbeitungsvorverarbeitung, um ein hohes Maß an Systemintegration bei geringer Systemleistung und niedrigen Kosten zu erreichen. Die Pin– und Software–kompatiblen Mitglieder der TDA4–Produktfamilie ermöglichen die Skalierbarkeit auf leistungsstärkere oder kostengünstigere Systeme für fortschrittliche einzelne und multimodale ADAS–Sensorfusionsanwendungen.

„Indem wir die Stärken von Texas Instruments und Arm nutzen, verbessern wir die Funktionalität von LeddarVision und leisten einen Beitrag zur Zukunft der Sicherheit und Autonomie im Automobil. Gemeinsam gestalten wir die Industriestandards neu“, erklärte Heinz Oyrer, Director of Strategic Partnerships bei LeddarTech.

Buchen Sie einen Termin mit LeddarTech auf der AutoSens Europe für eine Live–Demonstration im LeddarNavigator und überzeugen Sie sich von den Vorteilen der KI–basierten Low–Level–Fusion LeddarVision–Produkte, einschließlich LVS–2+ und LVF–E. Diese Lösungen sind so konzipiert, dass sie die strengen 5–Sterne–NCAP 2025/GSR 2022–Sicherheitsstandards erfüllen, und werden durch rigorose Forschung und Entwicklung in unseren Einrichtungen in Tel Aviv, Montreal und Quebec City validiert. Die wichtigsten Leistungsindikatoren werden den Kunden auf Anfrage zur Verfügung gestellt.

Verfolgen Sie den europäischen Roadtrip auf unserer Website „LeddarNavigator Diaries“.

Über LeddarTech

LeddarTech ist ein 2007 gegründetes globales Softwareunternehmen mit Hauptsitz in Québec City und weiteren Forschungs– und Entwicklungszentren in Montreal und Tel Aviv, Israel. LeddarTech entwickelt und liefert umfassende KI–gestützte Low–Level–Sensorfusions– und Wahrnehmungssoftwarelösungen, die den Einsatz von ADAS– und autonomen Fahranwendungen ermöglichen. Die Software von LeddarTech, die für die Automobilindustrie ausgelegt ist, wendet zum Erstellen präziser 3D–Modelle der Umgebung fortschrittliche KI– und Computer–Vision–Algorithmen an, um eine bessere Entscheidungsfindung und sicherere Navigation zu erreichen. Diese leistungsstarke, skalierbare und kosteneffiziente Technologie steht OEMs und Tier–1/2–Zulieferern für die effiziente Implementierung von ADAS–Lösungen für PKWs und Geländefahrzeuge zur Verfügung.

LeddarTech ist für mehrere Innovationen im Bereich der Fernerkundung verantwortlich, mit über 160 Patentanmeldungen (87 erteilt), die die Fähigkeiten von ADAS, AD und Parken verbessern. Eine bessere Wahrnehmung rund um das Fahrzeug ist entscheidend, um die globale Mobilität sicherer, effizienter, nachhaltiger und erschwinglicher zu machen: Das ist es, was LeddarTech dazu bringt, die am weitesten verbreitete Softwarelösung für Sensorfusion und Wahrnehmung zu werden.

LeddarTech kann im Rahmen von Kooperationen, Partnerschaften und Projekten von Zeit zu Zeit mit Testfahrzeugen personenbezogene Daten erfassen, d. h. Informationen, die Mitglieder der Öffentlichkeit direkt oder indirekt identifizieren. Die erfassten personenbezogenen Daten können von LeddarTech im Rahmen der Entwicklung und Schulung unserer Software und Produkte verarbeitet, verwendet, gespeichert und weitergegeben werden. Weitere Informationen zu den Verarbeitungsaktivitäten, zu denen die Erhebung, Nutzung, Speicherung und Weitergabe der personenbezogenen Daten gehören, sowie zu den damit verbundenen Rechten zum Schutz personenbezogener Daten und deren Ausübung finden Sie in der Datenschutzrichtlinie von LeddarTech.

Weitere Informationen über LeddarTech finden Sie unter www.LeddarTech.com und auf LinkedIn, Twitter (X), Facebook und YouTube.

Zukunftsgerichtete Aussagen

Bestimmte Aussagen in dieser Pressemitteilung können als zukunftsgerichtete Aussagen im Sinne des US–amerikanischen Private Securities Litigation Reform Act von 1995, Abschnitt 27A des Securities Act von 1933 in der jeweils gültigen Fassung und Abschnitt 21E des Securities Exchange Act von 1934 in der jeweils gültigen Fassung (die auch zukunftsgerichtete Aussagen und zukunftsgerichtete Informationen im Sinne der geltenden kanadischen Wertpapiergesetze umfassen) angesehen werden, einschließlich, aber nicht beschränkt auf Aussagen über die voraussichtliche Strategie, zukünftige Geschäftstätigkeiten, Aussichten, Ziele und Finanzprognosen von LeddarTech und andere Finanzkennzahlen. Zukunftsgerichtete Aussagen beinhalten im Allgemeinen Aussagen, die vorausschauenden Charakter haben und von zukünftigen Ereignissen oder Bedingungen abhängen oder sich auf diese beziehen und Wörter wie „können“, „werden“, „sollten“, „würden“, „erwarten“, „antizipieren“, „planen“, „wahrscheinlich“, „glauben“, „schätzen“, „projizieren“, „beabsichtigen“ und andere ähnliche Ausdrücke enthalten. Aussagen, die nicht auf historischen Fakten beruhen, sind zukunftsorientierte Aussagen. Zukunftsgerichtete Aussagen beruhen auf aktuellen Einschätzungen und Annahmen, die Risiken und Ungewissheiten unterliegen, und stellen keine Garantie für zukünftige Leistungen dar. Die tatsächlichen Ergebnisse können aufgrund verschiedener Faktoren erheblich von denen abweichen, die in den zukunftsgerichteten Aussagen enthalten sind, einschließlich, aber nicht beschränkt auf: (i) die Möglichkeit, dass die erwarteten Vorteile des kürzlich erfolgten Unternehmenszusammenschlusses von LeddarTech nicht realisiert werden; (ii) das Risiko, dass Rechtsstreitigkeiten der Aktionäre im Zusammenhang mit dem Unternehmenszusammenschluss oder andere Vergleiche oder Untersuchungen zu erheblichen Kosten für Verteidigung, Entschädigung und Haftung führen; (iii) Änderungen der allgemeinen wirtschaftlichen und/oder branchenspezifischen Bedingungen; (iv) mögliche Störungen durch den Unternehmenszusammenschluss, die dem Geschäft von LeddarTech schaden könnten; (v) die Fähigkeit von LeddarTech, Schlüsselpersonal zu halten, zu gewinnen und einzustellen; (vi) mögliche negative Reaktionen oder Änderungen in den Beziehungen zu Kunden, Mitarbeitern, Lieferanten oder anderen Parteien; (vii) mögliche geschäftliche Unsicherheiten, einschließlich Änderungen bestehender Geschäftsbeziehungen nach dem Unternehmenszusammenschluss, die die finanzielle Leistungsfähigkeit von LeddarTech beeinträchtigen könnten; (viii) gesetzgeberische, behördliche und wirtschaftliche Entwicklungen; (ix) Unvorhersehbarkeit und Schwere von Katastrophenereignissen, einschließlich, aber nicht beschränkt auf Terrorakte, Ausbruch oder Eskalation von Krieg oder Feindseligkeiten und Epidemien, Pandemien oder Krankheitsausbrüche (einschließlich COVID–19) sowie die Reaktion des Managements auf die vorgenannten Faktoren; (x) der Zugang zu Kapital und Finanzierung und die Fähigkeit von LeddarTech, die Einhaltung von Schuldverpflichtungen aufrechtzuerhalten; (xi) die Fähigkeit von LeddarTech, sein Geschäftsmodell umzusetzen, Design Wins zu erzielen und bedeutende Einnahmen zu generieren; und (xii) andere Risikofaktoren, die von Zeit zu Zeit in den Berichten von LeddarTech, die bei der US–amerikanischen Securities and Exchange Commission (die „SEC“) eingereicht werden, erläutert werden, einschließlich der Risikofaktoren im Jahresbericht von in LeddarTech auf Formular 20–F für das Geschäftsjahr zum 30. September 2023. . Die vorstehende Liste der wichtigen Faktoren ist nicht erschöpfend. Sofern nicht durch geltendes Recht vorgeschrieben, übernimmt LeddarTech keine Verpflichtung, zukunftsgerichtete Aussagen zu revidieren oder zu aktualisieren oder andere zukunftsgerichtete Aussagen zu treffen, sei es aufgrund neuer Informationen, zukünftiger Events oder aus anderen Gründen.

Kontakt:
Daniel Aitken, Vice–President, Global Marketing, Communications and Investor Relations, LeddarTech Holdings Inc. Tel.: + 1–418–653–9000 Durchwahl 232 daniel.aitken@LeddarTech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision und die zugehörigen Logos sind Marken oder eingetragene Marken von LeddarTech Holdings Inc. und seinen Tochtergesellschaften. Alle anderen Marken und Produktnamen sind oder können Marken oder eingetragene Marken sein, die zur Identifizierung von Produkten oder Dienstleistungen ihrer jeweiligen Inhaber verwendet werden.

LeddarTech Holdings Inc. ist ein börsennotiertes Unternehmen, das an der Nasdaq unter dem Tickersymbol „LDTC“ geführt wird.

Ein Foto zu dieser Mitteilung finden Sie unter https://www.globenewswire.com/NewsRoom/AttachmentNg/7207016b–6eb5–4c0e–8821–f52cb6a9c84b


GLOBENEWSWIRE (Distribution ID 9250262)

Montana Technologies تعلن عن عرض تقنية AirJoule® في معرض تكنولوجيا المياه والطاقة والبيئة (ويتيكس) في دبي بالتعاون TenX Investment

رونان، مونتريال , Oct. 02, 2024 (GLOBE NEWSWIRE) —  أعلنت اليوم شركة Montana Technologies Corporation، المدرجة في بورصة ناسداك تحت الرمز (AIRJ)، والمطورة لتقنية AirJoule® التحويلية لتوليد مياه الغلاف الجوي، عن تأسيس أول مكتب دولي لها في دولة الإمارات العربية المتحدة لتسريع نشر تقنية AirJoule® في المنطقة.

صرّح رئيس شركة Montana Technologies، السيد Ramdas Rao، قائلاً: “سيساعدنا إنشاء مكتب في الإمارات العربية المتحدة على تلبية الطلب المتزايد على قدرات تقنية AirJoule المتقدمة لإزالة الرطوبة وجمع مياه الغلاف الجوي من العملاء المحتملين في الأسواق سريعة النمو في الإمارات ودول مجلس التعاون الخليجي والهند. كما يُعزّز وجودنا في الإمارات جهودنا لتعزيز استراتيجياتنا العالمية في نشر هذه التقنية التحويلية.”

وأضاف السيد Rao: “تُعتبر كفاءة تقنية AirJoule في توفير الأمن المائي والتبريد المريح الموفر للطاقة هي الأهم في السوق، كما تتمتع التقنية بالقدرة على دعم إزالة الكربون بشكل مسؤول، مع المساهمة في التنمية السريعة ونمو البنية التحتية الحيوية في المنطقة. حكومة الإمارات سباقة للغاية في جذب ودعم التقنيات المتطورة التي تساعد في تحقيق التنمية المستدامة، ونتطلع إلى العمل عن كثب مع شركائنا المحليين والاستراتيجيين، واستخدام الإمارات كمركز رئيسي لتعزيز انتشارنا الدولي.”

من جهة أخرى، أعلنت شركة Montana Technologies عن توقيع مذكرة تفاهم مع TenX Investment in Energy Enterprises & Management Co. LLC، وهي شركة استثمارية متخصصة مقرها دبي تركز على دعم الاستثمارات في مجالات الطاقة والمياه. من خلال هذا التعاون الاستراتيجي، تهدف TenX Investment إلى توفير الدعم التقني و اللوجستي للمكتب الإقليمي الجديد لشركة Montana Technologies في دولة الإمارات، مما يساعد في تسريع نشر تقنية AirJoule® في المنطقة.

تُعد TenX Investment شريكاً أساسياً في نجاح افتتاح المكتب الإقليمي في الإمارات، حيث تعمل على تسهيل الشراكات مع الجهات الحكومية والمحلية ودعم الجهود التسويقية التي تهدف إلى توسيع نطاق استخدام تقنية AirJoule®. يأتي هذا الدعم في إطار التزام TenX Investment بتعزيز الابتكار والاستدامة في قطاع الطاقة والمياه في الإمارات ودول مجلس التعاون الخليجي.

في هذا السياق، قال السيد Pat Eilers، الرئيس التنفيذي لشركة Montana Technologies: “تركز رؤية الإمارات 2030 بشكل كبير على الأمن المائي كأحد الجوانب الهامة في تحقيق أهداف التنمية المستدامة. ومن المتوقع أن تساهم قدرات تقنية AirJoule® في تعزيز الأمن المائي، ونحن متحمسون لتوسيع وجودنا في البلاد من خلال تأسيس مكتبنا الدولي، وبدعم من شريكنا الاستراتيجي TenX Investment، الذي يلعب دوراً محورياً في نجاح هذا المشروع.”

بالتزامن مع تأسيس مكتبها الدولي، ستعرض Montana Technologies تقنية AirJoule® في مؤتمر ويتيكس في دبي من 1 إلى 3 أكتوبر. يوفر معرض ويتيكس، الذي تنظمه هيئة كهرباء ومياه دبي، منصة لعرض التطورات التكنولوجية في مجالات الطاقة والمياه والموارد الطبيعية دعماً لرؤية دبي لبناء مستقبل مستدام. وتشجع الشركة الحضور في المعرض على زيارة جناحها (الجناح رقم F2–7) لمشاهدة عرض لوحدة AirJoule® لجمع المياه مباشرةً من الهواء والتخفيف من مشكلة ندرة المياه. بالإضافة إلى ذلك، يمكن دمج تقنية AirJoule® مع أنظمة التبريد بضغط البخار لتقليل استهلاك طاقة التكييف بنسبة تصل إلى 75%

Montana Technologies Corporation
Tom Divine – نائب الرئيس علاقات المستثمرين والتمويل
investors@mt.energ


GLOBENEWSWIRE (Distribution ID 9250236)

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

  • First program to combine Recursion’s end–to–end suite of AI–enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months
  • Plan to initiate dosing of Phase 1/2 in Q4 2024 to evaluate REC–1245 in a biomarker enriched patient population, including patients with solid tumors and lymphoma

SALT LAKE CITY, Oct. 02, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase 1/2 clinical trial of REC–1245, a new chemical entity for the treatment of biomarker–enriched solid tumors and lymphoma.

Chris Gibson, Ph.D., Co–founder and CEO of Recursion said, “REC–1245 is a prime example of using an expansive AI–enabled platform for drug discovery. After exploring many predicted biological and chemical relationships across our maps of biology, we identified RMB39 as a novel target that looks functionally similar to the well–known but hard to drug target CDK12. We also identified and optimized small molecules that target RBM39 without directly impacting CDK12 or CDK13 using these same AI–enabled maps. In under 18 months, leveraging some of our newer chemistry tools, Recursion rapidly progressed REC–1245 from novel target biology to preclinical drug candidate, more than twice the speed of industry average.”

Recursion identified the novel regulatory role of RBM39 associated with CDK12 using its maps of biology and first reported this relationship in early 2023 at Download Day, Recursion’s R&D and investor event. Recursion believes the modulation of RBM39 may be associated with a therapeutic effect in certain biomarker–enriched solid tumors and lymphoma. Additionally, Recursion estimates that the initially addressable population for this potential therapeutic to be >100,000 patients in the US and EU5. REC–1245 is a potent and selective RBM39 degrader with a potential first–in–class profile. Preclinical data support that RBM39 degradation induces splicing defects which downregulate DNA Damage Response (DDR) networks and cell cycle checkpoints.

“RBM39 degraders may offer a promising therapeutic approach for patients with solid tumors, particularly those with limited treatment options,” said Najat Khan, Ph.D., Chief R&D Officer and Chief Commercial Officer at Recursion. “Recursion’s platform was among the first to rapidly uncover the therapeutic potential of RBM39 degradation, a finding now validated by independent research. This mechanism provides new opportunities for targeting tumors, which are often resistant to conventional treatments. By advancing this research, we aim to deliver a critical option for patients facing significant unmet needs, ultimately improving their prognosis and quality of life.”

The Phase 1/2 clinical trial will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and potential monotherapy efficacy of REC–1245, and is expected to initiate in Q4 2024.

About Recursion

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine–learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, London, and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

Forward–Looking Statements

This document contains information that includes or is based upon “forward–looking statements” within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding the potential efficacy of REC–1245; timing of and plans to initiate dosing of Phase 1 clinical trial of REC–1245; early and late stage discovery, preclinical, and clinical programs; licenses and collaborations; prospective products and their potential future indications and market opportunities; Recursion OS and other technologies; business and financial plans and performance; and all other statements that are not historical facts. Forward–looking statements may or may not include identifying words such as “plan,” “will,” “expect,” “anticipate,” “intend,” “believe,” “potential,” “continue,” and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10–K and Quarterly Reports on Form 10–Q. All forward–looking statements are based on management’s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.


GLOBENEWSWIRE (Distribution ID 9249970)

Zoom Appoints Michelle Chang as Chief Financial Officer

SAN JOSE, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications (NASDAQ: ZM), today announced that Michelle Chang has been appointed as its Chief Financial Officer (CFO), effective October 7, 2024. Chang brings more than 25 years of experience in financial leadership roles, most recently serving as Corporate Vice President and CFO of Microsoft’s Commercial Sales & Partner Organization.

Reporting directly to Zoom’s founder and CEO Eric S. Yuan, Chang will be responsible for overseeing Zoom’s financial strategy, and will lead the global finance organization, including investor relations, tax, accounting and FP&A. Chang will succeed Kelly Steckelberg, who as previously announced, will continue to serve in an advisory capacity until the announcement of financial results for Zoom’s third fiscal quarter ending October 31, 2024.

“We are thrilled to welcome Michelle to Zoom as we continue to drive innovation, growth and value creation across our platform, especially as we advance our Zoom 2.0 vision and AI–first work platform strategy,” said Yuan. “Michelle is a results and values–driven leader with a strong track record of overseeing and implementing growth initiatives while developing and engaging talent across functions.”

“I’m excited to join Zoom as the company executes on its mission to deliver customer happiness by providing an innovative platform that enables the future of workplace communications and collaboration,” said Chang. “I look forward to rolling up my sleeves and working with the entire Zoom team to help support customers, as well as drive long–term growth and shareholder value.”

About Michelle Chang

Michelle Chang brings over 25 years of extensive leadership and finance experience to Zoom. Most recently, she was Corporate Vice President and CFO of Microsoft Commercial Sales & Partner Organization. Prior to that, she served in numerous leadership positions at Microsoft, including Corporate Vice President and CFO of Modern Workplace (including Office and Teams) & Cyber Security, among others. Her prior experience creating strong teams and collaborative partnerships across engineering and go–to–market illustrates the critical strategic value creation she will bring to Zoom. Chang started her career as an Audit & Consulting Senior at Arthur Andersen. She has a B.A. in Accounting from The University of Washington and is a Board Member of Kindering.

About Zoom

Zoom’s mission is to provide one platform that delivers limitless human connection. Reimagine teamwork with Zoom Workplace — Zoom’s open collaboration platform with AI Companion that empowers teams to be more productive. Together with Zoom Workplace, Zoom’s Business Services for sales, marketing, and customer care teams, including Zoom Contact Center, strengthen customer relationships throughout the customer lifecycle. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more information at zoom.com.

Forward–Looking Statements

This press release contains express and implied “forward–looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding expectations of Zoom’s continued growth and the expected benefits of Zoom 2.0 and Zoom’s AI–first work platform strategy. By their nature, these statements are subject to numerous uncertainties and risks, including factors beyond Zoom’s control, that could cause actual results, performance or achievement to differ materially and adversely from those anticipated or implied in the statements, including declines in new customers, renewals or upgrades, or decline in demand for Zoom’s platform, inability to respond to rapid technological changes, extend Zoom’s platform or develop new features, as well as those additional risks and uncertainties described under the caption “Risk Factors” and elsewhere in Zoom’s most recent filings with the Securities and Exchange Commission, including its quarterly report on Form 10–Q for the second fiscal quarter ended July 31, 2024. Forward–looking statements speak only as of the date the statements are made and are based on information available to Zoom at the time those statements are made and/or management's good faith belief as of that time with respect to future events. Zoom assumes no obligation to update forward–looking statements to reflect events or circumstances after the date they were made, except as required by law.

Contacts

Public Relations
Colleen Rodriguez
Head of Global PR for Zoom
press@zoom.us

Investor Relations
Charles Eveslage
Head of Investor Relations for Zoom
investors@zoom.us


GLOBENEWSWIRE (Distribution ID 9249144)